APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alinia (nitazoxanide)

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Selected research

Market Structure

Global Alinia (nitazoxanide) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025178 pages

Choose your research edition.

Industry ResearchAlinia (nitazoxanide) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Alinia (nitazoxanide) Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Alinia (nitazoxanide) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alinia (nitazoxanide) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Alinia (nitazoxanide) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.

This report provides an overview of the global Alinia (nitazoxanide) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Alinia (nitazoxanide) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alinia (nitazoxanide) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alinia (nitazoxanide) market size, projected growth trends, production technologies, key applications, and end-use industries.

Alinia (nitazoxanide) Segment by Company

Romark Laboratories

Chugai Pharmaceutical

Lupin

Alinia (nitazoxanide) Segment by Type

Tablets

Oral Suspension

Alinia (nitazoxanide) Segment by Application

Retail Pharmacy

Hospital

Others

Alinia (nitazoxanide) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alinia (nitazoxanide) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alinia (nitazoxanide) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alinia (nitazoxanide).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alinia (nitazoxanide) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alinia (nitazoxanide) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alinia (nitazoxanide) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alinia (nitazoxanide) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alinia (nitazoxanide) Industry Trends Table 2. Alinia (nitazoxanide) Industry Drivers Table 3. Alinia (nitazoxanide) Industry Opportunities and Challenges Table 4. Alinia (nitazoxanide) Industry Restraints Table 5. Global Alinia (nitazoxanide) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alinia (nitazoxanide) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alinia (nitazoxanide) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Alinia (nitazoxanide) Sales Market Share by Manufacturers Table 9. Global Alinia (nitazoxanide) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Alinia (nitazoxanide) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alinia (nitazoxanide) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alinia (nitazoxanide) Manufacturers, Product Type & Application Table 13. Global Alinia (nitazoxanide) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alinia (nitazoxanide) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Oral Suspension Table 18. Global Alinia (nitazoxanide) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 20. Global Alinia (nitazoxanide) Sales by Type (2027-2032) & (K Units) Table 21. Global Alinia (nitazoxanide) Sales Market Share by Type (2021-2026) Table 22. Global Alinia (nitazoxanide) Sales Market Share by Type (2027-2032) Table 23. Global Alinia (nitazoxanide) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Alinia (nitazoxanide) Revenue by Type (2021-2026) & (K Units) Table 25. Global Alinia (nitazoxanide) Revenue by Type (2027-2032) & (K Units) Table 26. Global Alinia (nitazoxanide) Revenue Market Share by Type (2021-2026) Table 27. Global Alinia (nitazoxanide) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacy Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Others Table 31. Global Alinia (nitazoxanide) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 33. Global Alinia (nitazoxanide) Sales by Application (2027-2032) & (K Units) Table 34. Global Alinia (nitazoxanide) Sales Market Share by Application (2021-2026) Table 35. Global Alinia (nitazoxanide) Sales Market Share by Application (2027-2032) Table 36. Global Alinia (nitazoxanide) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Alinia (nitazoxanide) Revenue by Application (2021-2026) & (K Units) Table 38. Global Alinia (nitazoxanide) Revenue by Application (2027-2032) & (K Units) Table 39. Global Alinia (nitazoxanide) Revenue Market Share by Application (2021-2026) Table 40. Global Alinia (nitazoxanide) Revenue Market Share by Application (2027-2032) Table 41. Global Alinia (nitazoxanide) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Alinia (nitazoxanide) Sales by Region (2021-2026) & (K Units) Table 43. Global Alinia (nitazoxanide) Sales Market Share by Region (2021-2026) Table 44. Global Alinia (nitazoxanide) Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Alinia (nitazoxanide) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Alinia (nitazoxanide) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 48. North America Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 49. Europe Alinia (nitazoxanide) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 51. Europe Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Alinia (nitazoxanide) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Alinia (nitazoxanide) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 58. Global Alinia (nitazoxanide) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Alinia (nitazoxanide) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Alinia (nitazoxanide) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Alinia (nitazoxanide) Revenue Market Share by Region (2021-2026) Table 62. Global Alinia (nitazoxanide) Revenue Market Share by Region (2027-2032) Table 63. Romark Laboratories Company Information Table 64. Romark Laboratories Business Overview Table 65. Romark Laboratories Alinia (nitazoxanide) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Romark Laboratories Alinia (nitazoxanide) Product Portfolio Table 67. Romark Laboratories Recent Development Table 68. Chugai Pharmaceutical Company Information Table 69. Chugai Pharmaceutical Business Overview Table 70. Chugai Pharmaceutical Alinia (nitazoxanide) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio Table 72. Chugai Pharmaceutical Recent Development Table 73. Lupin Company Information Table 74. Lupin Business Overview Table 75. Lupin Alinia (nitazoxanide) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Lupin Alinia (nitazoxanide) Product Portfolio Table 77. Lupin Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Alinia (nitazoxanide) Distributors List Table 81. Alinia (nitazoxanide) Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Alinia (nitazoxanide) Product Image Figure 2. Global Alinia (nitazoxanide) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alinia (nitazoxanide) Market Size (2021-2032) & (US$ Million) Figure 4. Global Alinia (nitazoxanide) Sales (2021-2032) & (K Units) Figure 5. Global Alinia (nitazoxanide) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Alinia (nitazoxanide) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Oral Suspension Image Figure 10. Global Alinia (nitazoxanide) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Alinia (nitazoxanide) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Alinia (nitazoxanide) Sales Market Share by Type (2021-2032) Figure 13. Global Alinia (nitazoxanide) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Alinia (nitazoxanide) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Alinia (nitazoxanide) Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacy Image Figure 17. Hospital Image Figure 18. Others Image Figure 19. Global Alinia (nitazoxanide) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Alinia (nitazoxanide) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Alinia (nitazoxanide) Sales Market Share by Application (2021-2032) Figure 22. Global Alinia (nitazoxanide) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Alinia (nitazoxanide) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Alinia (nitazoxanide) Revenue Market Share by Application (2021-2032) Figure 25. North America Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Alinia (nitazoxanide) Sales Market Share by Country (2021-2032) Figure 27. U.S. Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Alinia (nitazoxanide) Sales Market Share by Country (2021-2032) Figure 32. Germany Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Alinia (nitazoxanide) Sales Market Share by Country (2021-2032) Figure 39. China Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Alinia (nitazoxanide) Sales Market Share by Country (2021-2032) Figure 47. Brazil Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Alinia (nitazoxanide) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Alinia (nitazoxanide) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Alinia (nitazoxanide) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Figure 58. North America Alinia (nitazoxanide) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Alinia (nitazoxanide) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Alinia (nitazoxanide) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Alinia (nitazoxanide) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Alinia (nitazoxanide) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Alinia (nitazoxanide) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Suspension
Applications
  • Retail Pharmacy
  • Hospital
  • Others
Companies covered
  • Romark Laboratories
  • Chugai Pharmaceutical
  • Lupin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alinia (nitazoxanide) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alinia (nitazoxanide) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alinia (nitazoxanide) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alinia (nitazoxanide) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alinia (nitazoxanide) Market Dynamics
  1. 2.1 Alinia (nitazoxanide) Industry Trends
  2. 2.2 Alinia (nitazoxanide) Industry Drivers
  3. 2.3 Alinia (nitazoxanide) Industry Opportunities and Challenges
  4. 2.4 Alinia (nitazoxanide) Industry Restraints
3 Alinia (nitazoxanide) Market by Manufacturers
  1. 3.1 Global Alinia (nitazoxanide) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alinia (nitazoxanide) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alinia (nitazoxanide) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alinia (nitazoxanide) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alinia (nitazoxanide) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alinia (nitazoxanide) Manufacturers, Product Type & Application
  7. 3.7 Global Alinia (nitazoxanide) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alinia (nitazoxanide) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alinia (nitazoxanide) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alinia (nitazoxanide) Tier 1, Tier 2, and Tier 3
4 Alinia (nitazoxanide) Market by Type
  1. 4.1 Alinia (nitazoxanide) Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Oral Suspension
  4. 4.2 Global Alinia (nitazoxanide) Sales by Type
  5. 4.2.1 Global Alinia (nitazoxanide) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alinia (nitazoxanide) Sales by Type (2021-2032)
  7. 4.2.3 Global Alinia (nitazoxanide) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Alinia (nitazoxanide) Revenue by Type
  9. 4.3.1 Global Alinia (nitazoxanide) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alinia (nitazoxanide) Revenue by Type (2021-2032)
  11. 4.3.3 Global Alinia (nitazoxanide) Revenue Market Share by Type (2021-2032)
5 Alinia (nitazoxanide) Market by Application
  1. 5.1 Alinia (nitazoxanide) Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Alinia (nitazoxanide) Sales by Application
  6. 5.2.1 Global Alinia (nitazoxanide) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alinia (nitazoxanide) Sales by Application (2021-2032)
  8. 5.2.3 Global Alinia (nitazoxanide) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Alinia (nitazoxanide) Revenue by Application
  10. 5.3.1 Global Alinia (nitazoxanide) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Alinia (nitazoxanide) Revenue by Application (2021-2032)
  12. 5.3.3 Global Alinia (nitazoxanide) Revenue Market Share by Application (2021-2032)
6 Global Alinia (nitazoxanide) Sales by Region
  1. 6.1 Global Alinia (nitazoxanide) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alinia (nitazoxanide) Sales by Region (2021-2032)
  3. 6.2.1 Global Alinia (nitazoxanide) Sales by Region (2021-2026)
  4. 6.2.2 Global Alinia (nitazoxanide) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alinia (nitazoxanide) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alinia (nitazoxanide) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alinia (nitazoxanide) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alinia (nitazoxanide) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alinia (nitazoxanide) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alinia (nitazoxanide) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alinia (nitazoxanide) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alinia (nitazoxanide) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alinia (nitazoxanide) Revenue by Region
  1. 7.1 Global Alinia (nitazoxanide) Revenue by Region
  2. 7.1.1 Global Alinia (nitazoxanide) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alinia (nitazoxanide) Revenue by Region (2021-2026)
  4. 7.1.3 Global Alinia (nitazoxanide) Revenue by Region (2027-2032)
  5. 7.1.4 Global Alinia (nitazoxanide) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alinia (nitazoxanide) Revenue (2021-2032)
  8. 7.2.2 North America Alinia (nitazoxanide) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alinia (nitazoxanide) Revenue (2021-2032)
  11. 7.3.2 Europe Alinia (nitazoxanide) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alinia (nitazoxanide) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alinia (nitazoxanide) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alinia (nitazoxanide) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alinia (nitazoxanide) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Romark Laboratories
  2. 8.1.1 Romark Laboratories Company Information
  3. 8.1.2 Romark Laboratories Business Overview
  4. 8.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Romark Laboratories Alinia (nitazoxanide) Product Portfolio
  6. 8.1.5 Romark Laboratories Recent Developments
  7. 8.2 Chugai Pharmaceutical
  8. 8.2.1 Chugai Pharmaceutical Company Information
  9. 8.2.2 Chugai Pharmaceutical Business Overview
  10. 8.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio
  12. 8.2.5 Chugai Pharmaceutical Recent Developments
  13. 8.3 Lupin
  14. 8.3.1 Lupin Company Information
  15. 8.3.2 Lupin Business Overview
  16. 8.3.3 Lupin Alinia (nitazoxanide) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lupin Alinia (nitazoxanide) Product Portfolio
  18. 8.3.5 Lupin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alinia (nitazoxanide) Value Chain Analysis
  2. 9.1.1 Alinia (nitazoxanide) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alinia (nitazoxanide) Production Mode & Process
  6. 9.2 Alinia (nitazoxanide) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alinia (nitazoxanide) Distributors
  9. 9.2.3 Alinia (nitazoxanide) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst